Citadel Advisors’s Forte Biosciences FBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-324
| Closed | -$4.35K | – | 6045 |
|
|
2024
Q2 | $4.35K | Sell |
324
-805
| -71% | -$10.8K | ﹤0.01% | 5600 |
|
|
2024
Q1 | $19.8K | Buy |
1,129
+784
| +227% | +$13.7K | ﹤0.01% | 5553 |
|
|
2023
Q4 | $7.08K | Buy |
+345
| New | +$7.08K | ﹤0.01% | 5581 |
|
|
2023
Q3 | – | Sell |
-900
| Closed | -$23.4K | – | 6052 |
|
|
2023
Q2 | $23.4K | Buy |
900
+897
| +29,900% | +$23.3K | ﹤0.01% | 5216 |
|
|
2023
Q1 | $68 | Sell |
3
-180
| -98% | -$4.08K | ﹤0.01% | 5843 |
|
|
2022
Q4 | $4.57K | Buy |
+183
| New | +$4.57K | ﹤0.01% | 5801 |
|
|
2022
Q3 | – | Sell |
-3,255
| Closed | -$106K | – | 6115 |
|
|
2022
Q2 | $106K | Sell |
3,255
-6,014
| -65% | -$196K | ﹤0.01% | 5271 |
|
|
2022
Q1 | $338K | Sell |
9,269
-679
| -7% | -$24.8K | ﹤0.01% | 4829 |
|
|
2021
Q4 | $533K | Buy |
9,948
+7,858
| +376% | +$421K | ﹤0.01% | 4528 |
|
|
2021
Q3 | $155K | Buy |
2,090
+1,696
| +430% | +$126K | ﹤0.01% | 5589 |
|
|
2021
Q2 | $331K | Sell |
394
-4,214
| -91% | -$3.54M | ﹤0.01% | 5111 |
|
|
2021
Q1 | $3.95M | Sell |
4,608
-9,822
| -68% | -$8.42M | ﹤0.01% | 2385 |
|
|
2020
Q4 | $13.1M | Buy |
14,430
+805
| +6% | +$733K | ﹤0.01% | 1096 |
|
|
2020
Q3 | $16.5M | Buy |
+13,625
| New | +$16.5M | ﹤0.01% | 836 |
|
|
2020
Q2 | – | Sell |
-123
| Closed | -$56K | – | 4832 |
|
|
2020
Q1 | $56K | Buy |
+123
| New | +$56K | ﹤0.01% | 4519 |
|
|
2019
Q4 | – | Sell |
-206
| Closed | -$51K | – | 4763 |
|
|
2019
Q3 | $51K | Sell |
206
-73
| -26% | -$18.1K | ﹤0.01% | 4356 |
|
|
2019
Q2 | $700K | Buy |
+279
| New | +$700K | ﹤0.01% | 3266 |
|
|
2019
Q1 | – | Sell |
-61
| Closed | -$186K | – | 4668 |
|
|
2018
Q4 | $186K | Buy |
61
+18
| +42% | +$54.9K | ﹤0.01% | 3872 |
|
|
2018
Q3 | $251K | Buy |
+43
| New | +$251K | ﹤0.01% | 3599 |
|